Silence Therapeutics raises five million pounds

Biotechnology firm Silence Therapeutics announced a five million pound placing to Henderson Global Investors and Ora Capital.

Biotechnology firm Silence Therapeutics announced a five million pound placing to Henderson Global Investors and Ora Capital.

New shares were placed at 2.5p representing a discount of around 19% to the market price.

Subscribe to MoneyWeek

Become a smarter, better informed investor with MoneyWeek.

Funds raised will be used to expand the group's research activities in short interfering RNA or ribonucleic acid and micro RNA therapies, it said.

The group specialises in RNA interference therapeutics or 'gene silencing', which can shut down or control faulty genes for the treatment of cancer and other diseases.

Advertisement - Article continues below

"The proceeds of the subscription will enhance the company's financial position and provide it with sufficient cash resources to fund the business well into 2014, even without generating any revenue," Silence said in a company statement.

The group also confirmed that shareholder Robert Keith has given written notice to convert his £1m loan note into 200,000,000 new ordinary shares at 0.5p per share bringing his stake holding to just over 26%.

Director of Corporate Strategy Ali Mortazavi said: "We are delighted to welcome Henderson as a significant shareholder in Silence. Along with further support from our existing shareholders, the company is now ideally placed to take advantage of the new wave in RNAi therapeutics."

Shares in Silence soared 12.5% to 3.60p at 13:30.




Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020
Share tips

Class acts going cheap: buy into Europe’s best bargains

Value investing appears to be making a comeback, while shares on this side of the Atlantic are more appealing on metrics such as price/earnings ratios…
16 Jan 2020

Most Popular


What does the coronavirus crisis mean for UK house prices?

With the whole country in lockdown, the UK property market is closed for business. John Stepek looks at what that means for UK house prices, housebuil…
27 Mar 2020

Coronavirus: what it means for your mortgage or your rent

Ruth Jackson-Kirby looks at all the key questions for owners, renters and landlords affected by the coronavirus crisis.
29 Mar 2020
Small business

Furlough: what does it mean and how does it affect me?

Many companies have “furloughed” employees after they have shut down because of the coronavirus. But what does furlough mean and how does the scheme w…
30 Mar 2020

Buy stocks for the long term, but buy very carefully

After the wild ride of the last couple of weeks, equities are no longer expensive. But if you do decide to buy, be very, very careful indeed, says Mer…
30 Mar 2020